Verona Pharma plc (VRNA)
NASDAQ: VRNA · IEX Real-Time Price · USD
16.09
-0.41 (-2.48%)
At close: Mar 28, 2024, 4:00 PM
16.65
+0.56 (3.48%)
After-hours: Mar 28, 2024, 5:43 PM EDT

Verona Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Net Income
-54.37-68.7-55.57-65.15-40.56-25.27-26.03-6.37-9.52
Depreciation & Amortization
0.680.640.630.620.510.010.010.010.01
Share-Based Compensation
19.0114.1225.4322.183.123.683.710.730.51
Other Operating Activities
-15.54-5.92-3.74-2.73-5.94-7.25-5.01-3.410.04
Operating Cash Flow
-50.22-59.86-33.25-45.08-42.87-28.83-27.32-9.04-8.96
Capital Expenditures
0-0.03-0.01-0.08-0.05-0.02-0.01-0.02-0
Change in Investments
0009.7947.375.93-62.7100
Other Investing Activities
-----0.8-0.1-0.04-0.12
Investing Cash Flow
0-0.03-0.019.7147.316.71-62.83-0.05-0.12
Share Issuance / Repurchase
58.86151.170.73200.200056.830
Debt Issued / Paid
38.73.910500000
Other Financing Activities
-4.69-14.26-6.85-12.86--80.32-4.5-
Financing Cash Flow
92.87140.82-6.12192.340080.3252.330
Exchange Rate Effect
1.3-1.48-0.220.580.741.49-1.810.870.01
Net Cash Flow
43.9579.45-39.61157.565.19-16.29-8.7945.18-8.19
Free Cash Flow
-50.22-59.89-33.27-45.16-42.92-28.85-27.33-9.06-8.96
Free Cash Flow Margin
--13076.64%-83.17%------
Free Cash Flow Per Share
-0.63-0.91-0.55-1.05-3.26-2.20-2.13-0.70-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).